Company · CIK 0001830487 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Pharvaris N.V. · PHVS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 SForm 4 → | Sep 25, 1:35 pm EDT | Viviane MongesDirector | 11,969 | $33.05 | $395,524 | 5,500 | −68.5% | |
| Sep 23, 2026 MForm 4 → | Sep 25, 1:35 pm EDT | Viviane MongesDirector | 11,969 | $8.05 | $96,350 | 17,469 | — | |
| Sep 22, 2026 MForm 4 → | Sep 24, 4:03 pm EDT | Peng LuPresident | 45,308 | $2.59 | $117,348 | 110,261 | — | |
| Sep 22, 2026 SForm 4 → | Sep 24, 10:43 am EDT | Johannes Gerardus Christiaan Petrus SchikanDirector | 800 | $36.19 | $28,952 | 115,167 | −0.69% | |
| Sep 22, 2026 MForm 4 → | Sep 24, 10:43 am EDT | Johannes Gerardus Christiaan Petrus SchikanDirector | 800 | $20.00 | $16,000 | 115,967 | — | |
| Sep 21, 2026 GForm 4 → | Sep 23, 10:06 am EDT | David W. NassifCFO / CLO | 500 | — | — | 113,800 | — | |
| Sep 21, 2026 SForm 4 → | Sep 23, 10:06 am EDT | David W. NassifCFO / CLO | 6,000 | $36.47 | $218,801 | 114,300 | −4.99% | |
| Sep 17, 2026 SForm 4 → | Sep 21, 4:20 pm EDT | Peng LuPresident | 100,000 | $35.00 | $3,500,000 | 64,953 | −60.6% | |
| Sep 17, 2026 MForm 4 → | Sep 21, 4:20 pm EDT | Peng LuPresident | 100,000 | $2.59 | $259,000 | 164,953 | — | |
| Sep 17, 2026 SForm 4 → | Sep 21, 4:18 pm EDT | Johannes Gerardus Christiaan Petrus SchikanDirector | 200,000 | $35.00 | $7,000,000 | 115,167 | −63.5% | |
| Sep 17, 2026 SForm 4 → | Sep 21, 3:20 pm EDT | Elisabeth BjorkDirector | 52,500 | $37.89 | $1,989,409 | 15,167 | −77.6% | |
| Sep 17, 2026 MForm 4 → | Sep 21, 3:20 pm EDT | Elisabeth BjorkDirector | 52,500 | $15.64 | $821,100 | 67,667 | — | |
| Sep 17, 2026 SForm 4 → | Sep 21, 3:16 pm EDT | Robert GlassmanDirector | 14,493 | $38.56 | $558,812 | 10,500 | −58.0% | |
| Sep 17, 2026 MForm 4 → | Sep 21, 3:16 pm EDT | Robert GlassmanDirector | 14,493 | $18.14 | $262,903 | 24,993 | — | |
| Sep 17, 2026 SForm 4 → | Sep 21, 3:13 pm EDT | Anne LesageChief Early Development | 20,000 | $38.27 | $765,466 | 73,969 | −21.3% | |
| Sep 17, 2026 MForm 4 → | Sep 21, 3:10 pm EDT | Berndt ModigChief Executive Officer, Director | 300,000 | $35.00 | $10,500,000 | 650,000 | — | |
| Sep 15, 2026 SForm 4 → | Sep 17, 1:22 pm EDT | Stefan Andreas AbeleChief Technical Ops Officer | 46,400 | $38.17 | $1,771,125 | 39,068 | −54.3% | |
| Sep 15, 2026 MForm 4 → | Sep 17, 1:22 pm EDT | Stefan Andreas AbeleChief Technical Ops Officer | 45,000 | $16.40 | $738,000 | 85,468 | — | |
| Sep 15, 2026 SForm 4 → | Sep 17, 9:18 am EDT | Robert GlassmanDirector | 8,667 | $38.27 | $331,716 | 10,500 | −45.2% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 9:18 am EDT | Robert GlassmanDirector | 8,667 | $22.31 | $193,361 | 19,167 | — | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 16, 2:07 pm EDT | Wim SouverijnsChief Commercial Officer | 26,090 | $39.23 | $1,023,575 | 39,021 | −40.1% | 10b5-1 |
| Sep 14, 2026 MForm 4 → | Sep 16, 2:07 pm EDT | Wim SouverijnsChief Commercial Officer | 20,000 | $17.43 | $348,600 | 65,111 | — | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 15, 2:15 pm EDT | Berndt ModigChief Executive Officer, Director | 2,291 | $39.40 | $90,276 | 128,334 | −1.75% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 15, 2:30 pm EDT | Peng LuPresident | 15,000 | $40.13 | $601,947 | 65,179 | −18.7% | 10b5-1 |
| Sep 11, 2026 FMForm 4 → | Sep 15, 2:30 pm EDT | Peng LuPresident | 15,226 | $3.11 | $47,387 | 64,953 | — | 10b5-1 |
| Sep 10, 2026 SForm 4 → | Sep 14, 12:29 pm EDT | Anne LesageChief Early Development | 30,000 | $38.30 | $1,149,084 | 56,450 | −34.7% | 10b5-1 |
| Sep 10, 2026 MForm 4 → | Sep 14, 12:29 pm EDT | Anne LesageChief Early Development | 30,000 | $8.05 | $241,500 | 86,450 | — | 10b5-1 |
| Sep 9, 2026 SForm 4 → | Sep 11, 12:25 pm EDT | Robert GlassmanDirector | 8,000 | $37.55 | $300,396 | 10,500 | −43.2% | 10b5-1 |
| Sep 9, 2026 MForm 4 → | Sep 11, 12:25 pm EDT | Robert GlassmanDirector | 8,000 | $20.00 | $160,000 | 18,500 | — | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 9, 11:19 am EDT | Peng LuPresident | 15,000 | $40.68 | $610,134 | 65,179 | −18.7% | 10b5-1 |
| Sep 8, 2026 MForm 4 → | Sep 9, 11:19 am EDT | Peng LuPresident | 15,000 | $2.59 | $38,850 | 80,179 | — | 10b5-1 |
| Aug 14, 2026 SForm 4 → | Aug 18, 11:49 am EDT | Berndt ModigChief Executive Officer, Director | 2,292 | $34.77 | $79,686 | 130,625 | −1.72% | 10b5-1 |
| Aug 11, 2026 FForm 4 → | Aug 13, 4:35 pm EDT | Peng LuPresident | 226 | $34.62 | $7,825 | 65,179 | — | |
| Jul 13, 2026 SForm 4 → | Jul 15, 1:08 pm EDT | Berndt ModigChief Executive Officer, Director | 2,292 | $34.97 | $80,154 | 132,917 | −1.70% | 10b5-1 |
| Jul 11, 2026 FForm 4 → | Jul 14, 3:46 pm EDT | Peng LuChief Medical Officer | 226 | $35.07 | $7,926 | 65,405 | — | |
| Jun 29, 2026 SForm 4 → | Jul 1, 7:06 pm EDT | Johannes Gerardus Christiaan Petrus SchikanDirector | 37,600 | $35.41 | $1,331,496 | 315,167 | −10.7% | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jul 1, 7:02 pm EDT | Anne LesageChief Early Development | 76,172 | $35.39 | $2,695,452 | 93,969 | −44.8% | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jul 1, 7:02 pm EDT | Anne LesageChief Early Development | 38,472 | $6.85 | $263,442 | 86,622 | — | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 29, 6:18 pm EDT | Johannes Gerardus Christiaan Petrus SchikanDirector | 2,400 | $35.10 | $84,250 | 352,767 | −0.68% | 10b5-1 |
| Jun 25, 2026 SForm 4 → | Jun 29, 6:41 pm EDT | Anne LesageChief Early Development | 4,600 | $35.12 | $161,560 | 131,669 | −3.38% | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 29, 6:41 pm EDT | Anne LesageChief Early Development | 2,300 | $4.73 | $10,871 | 58,750 | — | 10b5-1 |
| Jun 25, 2026 SForm 4 → | Jun 29, 6:18 pm EDT | Peng LuChief Medical Officer | 29,700 | $34.30 | $1,018,832 | 65,631 | −31.2% | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 29, 6:18 pm EDT | Peng LuChief Medical Officer | 29,700 | $2.59 | $76,923 | 80,331 | — | 10b5-1 |
| Jun 18, 2026 SForm 4 → | Jun 23, 5:07 pm EDT | Peng LuChief Medical Officer | 300 | $34.00 | $10,200 | 65,631 | −0.46% | 10b5-1 |
| Jun 18, 2026 MForm 4 → | Jun 23, 5:07 pm EDT | Peng LuChief Medical Officer | 300 | $2.59 | $777 | 65,931 | — | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 17, 5:51 pm EDT | Berndt ModigChief Executive Officer, Director | 2,291 | $31.07 | $71,173 | 135,209 | −1.67% | 10b5-1 |
| Jun 12, 2026 FForm 4 → | Jun 16, 5:50 pm EDT | Peng LuChief Medical Officer | 117 | $32.20 | $3,767 | 65,631 | — | |
| Jun 11, 2026 FForm 4 → | Jun 15, 5:22 pm EDT | Peng LuChief Medical Officer | 109 | $31.51 | $3,435 | 65,748 | — | |
| Jun 4, 2026 SForm 4 → | Jun 8, 2:53 pm EDT | Anna NijdamPrincipal Accounting Officer | 2,670 | $30.87 | $82,425 | 46,275 | −5.46% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 MForm 4 → | Sep 25, 1:35 pm EDT | Viviane MongesDirector | 11,969 | — | — | 9,031 | — | |
| Sep 22, 2026 MForm 4 → | Sep 24, 4:03 pm EDT | Peng LuPresident | 45,308 | — | — | 0 | — | |
| Sep 22, 2026 MForm 4 → | Sep 24, 10:43 am EDT | Johannes Gerardus Christiaan Petrus SchikanDirector | 800 | — | — | 34,200 | — | |
| Sep 17, 2026 MForm 4 → | Sep 21, 4:20 pm EDT | Peng LuPresident | 100,000 | — | — | 45,308 | — | |
| Sep 17, 2026 MForm 4 → | Sep 21, 3:20 pm EDT | Elisabeth BjorkDirector | 52,500 | — | — | 0 | — | |
| Sep 17, 2026 MForm 4 → | Sep 21, 3:16 pm EDT | Robert GlassmanDirector | 14,493 | — | — | 0 | — | |
| Sep 15, 2026 MForm 4 → | Sep 17, 1:22 pm EDT | Stefan Andreas AbeleChief Technical Ops Officer | 45,000 | — | — | 44,500 | — | |
| Sep 15, 2026 MForm 4 → | Sep 17, 9:18 am EDT | Robert GlassmanDirector | 8,667 | — | — | 0 | — | 10b5-1 |
| Sep 14, 2026 MForm 4 → | Sep 16, 2:07 pm EDT | Wim SouverijnsChief Commercial Officer | 20,000 | — | — | 95,000 | — | 10b5-1 |
| Sep 10, 2026 MForm 4 → | Sep 14, 12:29 pm EDT | Anne LesageChief Early Development | 8,000 | — | — | 15,000 | — | 10b5-1 |
| Sep 9, 2026 MForm 4 → | Sep 11, 12:25 pm EDT | Robert GlassmanDirector | 8,000 | — | — | 0 | — | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jul 1, 7:02 pm EDT | Anne LesageChief Early Development | 37,572 | — | — | 0 | — | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 29, 6:41 pm EDT | Anne LesageChief Early Development | 2,300 | — | — | 7,072 | — | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 29, 6:18 pm EDT | Peng LuChief Medical Officer | 29,700 | — | — | 175,308 | — | 10b5-1 |
| Jun 18, 2026 MForm 4 → | Jun 23, 5:07 pm EDT | Peng LuChief Medical Officer | 300 | — | — | 205,008 | — | 10b5-1 |